[1]闫俊,柴旭兵,刘立平,等.血滞通胶囊对脑梗死恢复期患者神经功能及社会活动功能的影响[J].西部中医药,2020,33(07):101-104.[doi:10.12174/j.issn.1004-6852.2020.07.26]
　YAN Jun,CHAI Xubing,LIU Liping,et al.Effects of Xuezhitong Capsules on Neurological Function and Social Activity in Convalescent Patients with Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2020,33(07):101-104.[doi:10.12174/j.issn.1004-6852.2020.07.26]
点击复制

血滞通胶囊对脑梗死恢复期患者神经功能及社会活动功能的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年07期
页码:
101-104
栏目:
出版日期:
2020-07-15

文章信息/Info

Title:
Effects of Xuezhitong Capsules on Neurological Function and Social Activity in Convalescent Patients with Cerebral Infarction
文章编号:
1004-6852(2020)07-0101-04
作者:
闫俊，柴旭兵，刘立平，朱葛敏，叶楠，高亚亚，杨莹，曹团平
1 西安市第五医院神经内科，陕西 西安 710082； 2 西安市中心医院神经内科
Author(s):
YAN Jun1, CHAI Xubing1△, LIU Liping1, ZHU Gemin2, YE Nan1, GAO Yaya1, YANG Ying1, CAO Tuanping1
1 Department of Neurology, Xi'an No.5 Hospital, Xi′an 710082, China; 2 Department of Neurology, Xi'an Central Hospital
关键词:
脑梗死; 恢复期; 神经功能; 社会活动功能; 血滞通胶囊; 中医药
Keywords:
cerebral infarction;  convalescent;  neurological function;  the function of social activity;  Xuezhitong capsules;  TCM
分类号:
R277
DOI:
10.12174/j.issn.1004-6852.2020.07.26
文献标志码:
B
摘要:
目的：探讨血滞通胶囊对脑梗死恢复期患者神经功能及社会活动功能的影响。方法：将急性缺血性卒中且经治疗后好转出院患者129例随机分为试验组61例和对照组68例。试验组给予阿司匹林肠溶片+瑞舒伐他汀钙+血滞通胶囊治疗，对照组给予阿司匹林肠溶片+瑞舒伐他汀钙治疗。治疗3月及6月后进行改良Rankin评分(modified Rankin Scale，mRS)及社会活动功能量表(functional activities questionnaire，FAQ)评估。结果：1)治疗3个月试验组致残率为14.8%(9/61)，低于对照组的30.9%(21/68)(P＜0.05)；两组间mRS评分、FAQ评分及社会活动功能障碍率比较差异无统计学意义(P＞0.05)；2)治疗6个月试验组致残率为4.9%(3/61)，低于对照组的17.6%(12/68)，同时mRS评分、FAQ评分及社会活动功能障碍率试验组低于对照组，差异有统计学意义(P＜0.05)。结论：阿司匹林肠溶片、瑞舒伐他汀钙联用血滞通胶囊可促进脑梗死恢复期患者神经功能及社会活动功能恢复，改善患者生存质量。
Abstract:
Objective: To discuss the effects of Xuezhitong capsules on neurological function and the function of social activity in convalescent patients with cerebral infarction (CI). Methods: A total of 129 patients who were suffering acute ischemic stroke and discharged after the therapy were randomized into 61 cases of the study group and 68 cases of the control group. The study group were treated by aspirin enteric-coated tablets+rosuvastatin calcium+Xuezhitong capsules, and the control group were given aspirin enteric-coated tablets+rosuvastatin calcium. To assess mRS scores and FAQ three and six months after treating. Results: 1) Disability rate of the study group three months after treating was 14.8%(9/61), lower than 30.9%(21/68) of the control group (P＜0.05), the difference had no statistical meaning in mRS scores, FAQ scores and social dysfunction rate between both groups(P＞0.05); 2) Disability rate of the study group six months after treating was 4.9%(3/61), lower than 17.6%(12/68) of the control group(P＜0.05), simultaneously, the study group was lower than the control group in mRS scores, FAQ scores and social dysfunction rate, and the difference had statistical meaning between both groups(P＜0.05). Conclusion: Aspirin enteric-coated tablets, rosuvastatin calcium and Xuezhitong capsules could promote the recovery of neurological function and the function of social activity, improve survival quality of the patients.

相似文献/References:

[1]张永全,张惠玉,仝树坡,等.急性脑梗死肝阳暴亢证患者血脂及经颅多普勒检查结果的相关性研究[J].西部中医药,2011,24(11):38.
[2]朱晓娜,李天浩.调脂柔脉颗粒治疗动脉粥样硬化性脑梗死的疗效评价[J].西部中医药,2012,25(10):77.
　ZHU Xiao-na,LI Tian-hao.Evaluation on Clinical Efficacy of TiaoZhi RouMai Granules in Treating Atherosclerotic Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2012,25(07):77.
[3]刘晓花.中医康复护理与常规内科护理对脑梗死患者功能康复的效果观察[J].西部中医药,2013,26(10):117.
　LIU Xiaohua.Observation on Therapeutic Effects of TCM Rehabilitation Care and Routine Care on Functional Rehabilitation of the Patients with Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2013,26(07):117.
[4]陈少兰,徐胜珍△.中西医结合护理对急性心肌梗死患者康复效果的影响[J].西部中医药,2014,27(04):129.
　CHEN Shaolan,XU Shengzhen.Influence of Nursing on the Patients with Acute Myocardial Infarction at Recovery Stage by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(07):129.
[5]祁瑞芳.同型半胱氨酸、超敏 C- 反应蛋白在 2 型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(08):152.
[6]王晓怀,寇嘉宁,潘文,等.黄芪注射液治疗脑梗死的Meta分析[J].西部中医药,2014,27(10):67.
[7]赵俊喜.督脉穴位注射疗法治疗脑梗死的疗效评价[J].西部中医药,2014,27(12):96.
[8]焦富成.阿加曲班联合参芎葡萄糖治疗进展性脑梗死35例[J].西部中医药,2014,27(02):112.
　JIAO Fucheng.Argatroban and ShenXiong Glucose for 35 Cases of Progressive Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(07):112.
[9]梁建,刘国华,李水桥,等.红花黄色素联合依达拉奉治疗急性脑梗死临床观察[J].西部中医药,2014,27(03):105.
　LIANG Jian,LIU Guohua,LI Shuiqiao,et al.Clinical Observation on Carthamin Yellow Combined with Edaravone in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(07):105.
[10]康庄.自拟中风活血化痰汤对急性脑梗死患者血清NSE、BDNF 水平的影响[J].西部中医药,2013,26(02):22.
　KANG Zhuang.Effects of Self-made ZhongFeng HuoXue HuaTanTang on Contents of Serum NSE and BDNF in Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2013,26(07):22.
[11]申艳方,杜菊梅,安书芬.丹黄通脉胶囊治疗气虚血瘀兼阴虚型脑梗死恢复期患者30例[J].西部中医药,2015,28(12):84.

备注/Memo

备注/Memo:
收稿日期：2019-03-17*基金项目：西安市科技计划项目(2017118SF/YX012)。作者简介：闫俊(1984—)，女，硕士学位，主治医师。研究方向：脑血管病、痴呆的诊治。△通讯作者：柴旭兵(1973—)，男，硕士学位，副主任医师。研究方向：脑血管病、神经内分泌疾病的诊治。
更新日期/Last Update: 2020-07-15